Sichuan Cancer Hospital And Research Institute
Clinical trials sponsored by Sichuan Cancer Hospital And Research Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Ancient chinese exercise tested for ostomy patients: could it ease fatigue and improve sleep? Results expected Oct 2026 (estimated)
- New tool aims to simplify tough choices for lung cancer patients Results expected Dec 2026 (estimated)
- New study explores how lung nodule patients make tough treatment choices Results expected Jun 2027 (estimated)
-
New hope for bile duct cancer: triple therapy shows promise after chemo fails
Disease control CompletedThis Phase 2 trial tested a combination of three treatments—local chemotherapy delivered via beads into the liver, a targeted drug called apatinib, and an immunotherapy (PD-1 antibody)—in 20 patients with advanced bile duct cancer that had worsened after standard first-line chemo…
Phase 2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug combo cuts chemo nausea in half for gynecologic cancer patients
Symptom relief CompletedThis study tested whether adding the drug aprepitant to standard anti-nausea medicine helps women with gynecologic cancers (like ovarian or cervical cancer) who are getting chemotherapy. 143 women took part. The goal was to see if the extra drug could better prevent nausea and vo…
Phase 3 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC